Granite Bio, a Basel-based startup rooted in Regensburg research, secures $100M to advance treatments for autoimmune diseases. A testament to the power of cross-border biotech collaboration!
transkript.de/artikel/2025/...
#GraniteBio
Granite Bio, a Basel-based startup rooted in Regensburg research, secures $100M to advance treatments for autoimmune diseases. A testament to the power of cross-border biotech collaboration!
transkript.de/artikel/2025/...
#GraniteBio
Granite Bio, a Basel-based startup rooted in Regensburg research, secures $100M to advance treatments for autoimmune diseases. A testament to the power of cross-border biotech collaboration!
transkript.de/artikel/2025/...
#GraniteBio
More Funding Raises: #Exowatt $70M Series A; #GraniteBio $70M Series B; #Nourish $70M Series B; #Fairmat €51.5M Series B; #Hawk $56M Series C; #Anecdotes $55M Series B; #Stitch $55M Series C; #Haball $52M pre-Series A; #Alpaca $52M Series C; #Aetherflux $50M Series A
NEWS: Swiss start-up #GraniteBio has carved out $100 million in a pair of #financings for its pipeline of potentially first-in-class #antibodies for autoimmune diseases.
pharmaphorum.com/news/granite...